RESUMO
Transgender individuals may transition to their identified gender through social, hormonal, and procedural methods by using a multidisciplinary team of health care providers, including dermatologists. In this review, we discuss the medical and aesthetic dermatologic needs related to the transitioning of transgender patients and provide therapeutic and procedural recommendations. In addition to routine cutaneous conditions, dermatologists may need to treat hormonal therapy-related complications. Acumen for genital dermatology and familiarity with gender reassignment surgery is important for the dermatologist caring for a transgender patient. From a structural standpoint, transgender beauty poses a unique aesthetic task. We identify key differences in the facial structure and physique of males versus those of females. Dermatologists may have a tremendous impact on the lives of transgender individuals who seek to realize their gender identity.
Assuntos
Técnicas Cosméticas , Estética , Pessoas Transgênero , Tecido Adiposo/transplante , Alopecia/induzido quimicamente , Alopecia/tratamento farmacológico , Contorno Corporal , Distribuição da Gordura Corporal , Preenchedores Dérmicos/efeitos adversos , Preenchedores Dérmicos/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Face/anatomia & histologia , Face/cirurgia , Feminino , Identidade de Gênero , Hormônios Esteroides Gonadais/efeitos adversos , Hormônios Esteroides Gonadais/farmacologia , Remoção de Cabelo/métodos , Hirsutismo/induzido quimicamente , Hirsutismo/tratamento farmacológico , Humanos , Masculino , Neurotoxinas/uso terapêutico , Complicações Pós-Operatórias/terapia , Procedimentos de Cirurgia Plástica , Caracteres Sexuais , Cirurgia de Readequação Sexual , Pele/efeitos dos fármacos , Pessoas Transgênero/psicologiaRESUMO
BACKGROUND: Robust and long-term data on true incidence of delayed-onset nodules and immune tolerance of hyaluronic acid (HA) fillers are lacking. OBJECTIVE: To characterize the incidence of delayed nodules in Vycross (VYC) HA fillers compared with previously reported FDA and non-FDA data of all HA fillers. METHODS AND MATERIALS: The incidence of delayed nodules in all patients who had received VYC fillers in a 12-month period was assessed through a retrospective chart review. Nodule incidence for currently approved nonanimal-stabilized hyaluronic acid (NASHA) fillers was assessed using the FDA Summary of Safety and Effectiveness Data. RESULTS: Overall, 1,029 patients received 1,250 VYC filler treatments. Five patients developed delayed nodules to VOB, with an incidence of 1.0% per patient and 0.8% per syringe. No nodules were observed in patients who received VLR or VOL. All nodules were treated successfully using a combination of intralesional triamcinolone and hyaluronidase. Compared with other currently approved NASHA fillers, VOB is associated with a higher incidence of nodule formation. CONCLUSION: The introduction of VYC HAs has introduced a new variable that may be changing the immune tolerance of these substances, resulting in a higher incidence of delayed nodules than previously expected.
Assuntos
Técnicas Cosméticas/efeitos adversos , Preenchedores Dérmicos/efeitos adversos , Toxidermias/etiologia , Dermatoses Faciais/induzido quimicamente , Ácido Hialurônico/efeitos adversos , Preenchedores Dérmicos/química , Toxidermias/imunologia , Dermatoses Faciais/imunologia , Feminino , Humanos , Ácido Hialurônico/química , Ácido Hialurônico/imunologia , Injeções Intradérmicas , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Medição de RiscoRESUMO
Oral antibiotics are well established treatments for acne vulgaris but are associated with undesirable side effects. Topical antibiotics offer an improved safety profile but have led to an alarming rise in worldwide P. acnes resistance. Fortunately, a new class of topical minocycline products has been developed for the treatment of acne and rosacea that decreases the risk for antibiotic resistance while maintaining safety and efficacy. Recent clinical studies have demonstrated that a hydrophilic minocycline gel (BPX-01) and a lipophilic minocycline foam (FMX101) both reduced acne lesion counts with negligible systemic absorption. Head-to-head studies have yet to be completed, but the hydrophilic gel studies reported greater treatment efficacy than the lipophilic foam studies. J Drugs Dermatol. 2019;18(3):240-244.
Assuntos
Acne Vulgar/tratamento farmacológico , Antibacterianos/farmacologia , Minociclina/farmacologia , Propionibacterium acnes/efeitos dos fármacos , Acne Vulgar/microbiologia , Acne Vulgar/patologia , Administração Cutânea , Antibacterianos/uso terapêutico , Ensaios Clínicos como Assunto , Farmacorresistência Bacteriana , Humanos , Minociclina/uso terapêutico , Pele/efeitos dos fármacos , Pele/patologia , Resultado do TratamentoAssuntos
Pessoas Transgênero , Transexualidade , Humanos , Neurotoxinas , Percepção , Estudos ProspectivosRESUMO
BACKGROUND: There is growing demand for cosmetic treatments in the younger population, yet counseling and treating this age group can be difficult to justify.
OBJECTIVE: Chronologic changes that cause noticeable signs of aging are discussed within each age group. Age-appropriate cosmetic preventions and interventions are therefore recommended.
METHODS: A PubMed search was performed for high quality trials and evidence based reviews on the basic science of aging, as well as on cosmetic modalities and their histological, biochemical, and clinical effects.
RESULTS AND CONCLUSIONS: Specific age-related changes occur with each decade of life. A complete understanding of when these physiologic changes occur helps determine age-appropriate cosmetic counseling, preventions, and interventions.
J Drugs Dermatol. 2017;16(6 Suppl):s81-83.
.Assuntos
Técnicas Cosméticas , Aconselhamento , Envelhecimento da Pele , Adolescente , Serviços de Saúde do Adolescente , Adulto , Fatores Etários , Medicina Baseada em Evidências , Humanos , Pessoa de Meia-Idade , Adulto JovemRESUMO
INTRODUCTION: Microneedling procedures are growing in popularity for a wide variety of skin conditions. This paper comprehensively reviews the medical literature regarding skin needling efficacy and safety in all skin types and in multiple dermatologic conditions.
METHODS: A PubMed literature search was conducted in all languages without restriction and bibliographies of relevant articles reviewed. Search terms included: "microneedling," "percutaneous collagen induction," "needling," "skin needling," and "dermaroller."
RESULTS: Microneedling is most commonly used for acne scars and cosmetic rejuvenation, however, treatment benefit has also been seen in varicella scars, burn scars, keloids, acne, alopecia, and periorbital melanosis, and has improved flap and graft survival, and enhanced transdermal delivery of topical products. Side effects were mild and self-limited, with few reports of post-inflammatory hyperpigmentation, and isolated reports of tram tracking, facial allergic granuloma, and systemic hypersensitivity.
DISCUSS: Microneedling represents a safe, cost-effective, and efficacious treatment option for a variety of dermatologic conditions in all skin types. More double-blinded, randomized, controlled trials are required to make more definitive conclusions.
J Drugs Dermatol. 2017;16(4):308-314.
.Assuntos
Cicatriz/terapia , Técnicas Cosméticas/instrumentação , Sistemas de Liberação de Medicamentos/métodos , Agulhas , Dermatopatias/terapia , Administração Cutânea , Ensaios Clínicos como Assunto , Técnicas Cosméticas/efeitos adversos , Fármacos Dermatológicos/administração & dosagem , Eritema/etiologia , Humanos , Hiperpigmentação/etiologia , Rejuvenescimento , Envelhecimento da Pele , Resultado do TratamentoRESUMO
Topical retinoids are currently approved by the US Food and Drug Administration for the treatment of acne vulgaris in nonpregnant, nonlactating patients 12 years of age and older. Their efficacy, safety, and tolerability are well documented for inflammatory and noninflammatory acne with studies repeatedly demonstrating a decrease in the number of lesions, significant improvement in acne severity, improvement in the cosmetic appearance of acne, and the prevention of acne lesions through microcomedone formation. There is some variability between prescription retinoid products regarding efficacy, safety, and tolerability; with erythema, peeling, and dryness being common, potential side effects. Due to their efficacious and safe profile, topical retinoids remain the first-line treatment for acne vulgaris.